2010 Annual Meeting | Diagnostic Dilemmas in Multiple Sclerosis

Date Monday 04/12/10

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Mark Keegan, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the broad spectrum of CNS demyelinating diseases, inflammatory, other myelopathies, and the differential diagnosis of mimickers of these conditions.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Interactive, Audience Participation

Event Timeline
02:15 PM - 02:55 PM		Spectrum of CNS Inflammatory Demyelinating Disorders Mark Keegan, MD, FAAN
02:55 PM - 03:35 PM		Diagnostic Challenges in Pediatric CNS Demyelinating Disease Brenda Banwell, MD, FAAN
03:35 PM - 03:45 PM		Questions and Answers
03:45 PM - 04:00 PM		Break
04:00 PM - 04:40 PM		Diagnostic Approach to Myelopathies Brian G. Weinshenker, MD, FAAN
04:40 PM - 05:20 PM		Rational Approach to Mimickers of Multiple Sclerosis Nuhad Abou Zeid, MD
05:20 PM - 05:45 PM		Case Discussions
05:45 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Mark Keegan, MD, FAAN	Dr. Keegan has received publishing royalties from a publication relating to health care.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
Brenda Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Nuhad Abou Zeid, MD	No disclosure on file